Do you have limited or no ability to use one or both hands?

 

You may be eligible to participate in our Brain-Computer Interface study!

 

Study Goal

The goal of this research study is to demonstrate somatosensory feedback-enabled neural control of high degree-of-freedom assistive devices. This will be accomplished by the use of two recording arrays implanted chronically in the motor cortex and two stimulation arrays implanted chronically in the somatosensory cortex of individuals with impaired upper limb function. Over the period of one year, we will have the opportunity to train participants to control devices such as a computer cursor or a robotic arm. Participants may also receive microstimulation in somatosensory regions of their brain which will enable them to feel cutaneous-like percepts.

As the training progresses, they will learn to control sophisticated, dexterous limbs in virtual environments, which simulate the capabilities provided by complex robotic manipulators. Finally, in a safe environment they will learn to use available robotics technology to perform tasks that represent important activities of daily living.

Study Summary

In this research study, a person’s own movement related brain signals are decoded and used to direct a robotic arm to accomplish meaningful tasks, such as self-feeding and grasping and moving objects. Very small microelectrode arrays are implanted on the surface of the brain for up to one year. These devices transmit neural (brain) signals which are processed and used to produce meaningful movement. Also, sensation of touch may be “felt” by stimulating the brain in tandem with the robotic arm grasping.

Placement of the arrays is temporary to evaluate their effectiveness, therefore there is no direct benefit to the participant. Information learned through this research study will support the development of a fully implantable neutrally controlled BMI system with movement and sensory capabilities. 

Individuals will be compensated for their research participation.

Principal Investigator:

Peter Warnke, MD

 

Primary Contact:

John Downey, PhD

 

Scroll to Top